Skip to content

7 March 2026

Canadian Health Policy

The journal of the Canadian Health Policy Institute

MORE
Articles
Opinions
Submissions
E-news

Search for:

Home
Opinions
Use COVID pause to reconsider drug-price regulation

Use COVID pause to reconsider drug-price regulation

Nigel Rawson and John Adams | Financial Post | Jan 18, 2021

Post navigation

Previous New patented medicines price regulation is dangerous and unjustified

Next Breaking vaccine patents will only make the next pandemic worse

MORE
Articles
Opinions
Submissions
E-news

Canadian Health Policy

The journal of the Canadian Health Policy Institute

Copyright © All rights reserved. | Theme: Elegant Magazine by AF themes.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.